Use

This germline-focused next‑generation sequencing panel is intended for the hereditary risk assessment of colorectal cancer by detecting germline variants in key cancer‑predisposition genes. It enables clinicians to identify inherited mutations that may influence cancer surveillance strategies and familial risk counseling.